Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model

American Journal of Epidemiology
Nicolas A MenziesJoshua A Salomon

Abstract

We estimated long-term tuberculosis (TB) trends in the US population and assessed prospects for TB elimination. We used a detailed simulation model allowing for changes in TB transmission, immigration, and other TB risk determinants. Five hypothetical scenarios were evaluated from 2017 to 2100: 1) maintain current TB prevention and treatment activities (base case); 2) provision of latent TB infection testing and treatment for new legal immigrants; 3) increased uptake of latent TB infection screening and treatment among high-risk populations, including a 3-month isoniazid-rifapentine regimen; 4) improved TB case detection; and 5) improved TB treatment quality. Under the base case, we estimate that by 2050, TB incidence will decline to 14 cases per million, a 52% (95% posterior interval (PI): 35, 67) reduction from 2016, and 82% (95% posterior interval: 78, 86) of incident TB will be among persons born outside of the United States. Intensified TB control could reduce incidence by 77% (95% posterior interval: 66, 85) by 2050. We predict TB may be eliminated in US-born but not non-US-born persons by 2100. Results were sensitive to numbers of people entering the United States with latent or active TB, and were robust to alternative ...Continue Reading

References

May 26, 1989·JAMA : the Journal of the American Medical Association
Jan 12, 2012·Epidemiology and Infection·A N HillK G Castro
Mar 28, 2012·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN Centers for Disease Control and Prevention, Public Health Service, U.S. Department Health
Jul 28, 2013·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Christopher H JacksonDaniela De Angelis
Mar 25, 2016·MMWR. Morbidity and Mortality Weekly Report·Jorge L SalinasAdam J Langer
Apr 16, 2016·PloS One·Courtney M YuenAnne Marie France
Jun 12, 2016·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·K G CastroP A LoBue
Feb 10, 2017·Health Promotion International·UNKNOWN World Health Organization
May 6, 2017·American Journal of Respiratory and Critical Care Medicine·Sourya ShresthaDavid W Dowdy
Aug 2, 2017·Vaccine· World Health Organization

❮ Previous
Next ❯

Citations

Oct 20, 2018·American Journal of Respiratory and Critical Care Medicine·Neil W Schluger
Apr 25, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Amish TalwarAdam J Langer
Jul 25, 2019·Public Health Reports·Suzanne M MarksAndrew N Hill
Nov 7, 2019·Clinical Trials : Journal of the Society for Clinical Trials·Kimberley N Chapman HedgesStefan V Goldberg
Oct 19, 2019·American Journal of Respiratory and Critical Care Medicine·Nicolas A MenziesPriya B Shete
Mar 7, 2020·The Korean Journal of Internal Medicine·Doosoo Jeon
Mar 20, 2020·MMWR. Morbidity and Mortality Weekly Report·Noah G SchwartzAdam J Langer
Jul 3, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C Robert Horsburgh
Jun 7, 2019·PLoS Medicine·Jonathon R CampbellKevin Schwartzman
Jun 27, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonardo Martinez, Jason R Andrews
Sep 23, 2020·BMC Public Health·Adam ReadheadRoger Detels
May 15, 2020·International Journal of Environmental Research and Public Health·Yiran CuiChuanhua Yu
Jan 1, 2018·Current Epidemiology Reports·Grace A NoppertJon Zelner
Aug 8, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·April C PettitUNKNOWN Tuberculosis Epidemiologic Studies Consortium (TBESC)
Nov 10, 2020·PloS One·John P BonnewellJason E Stout
Jul 10, 2020·American Journal of Respiratory and Critical Care Medicine·Nicolas A MenziesJoshua A Salomon
Mar 9, 2021·Annals of the American Thoracic Society·James D MancusoAndrew N Hill

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

MMWR. Morbidity and Mortality Weekly Report
Rebekah J StewartAdam J Langer
The Medical Journal of Australia
David W J Griffin, Mark D Kelly
© 2022 Meta ULC. All rights reserved